This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Jayne Chin: Innovator in Targeted Drug Delivery
Introduction
Jayne Chin is a notable inventor based in Warren, NJ (US), recognized for her contributions to the field of targeted drug delivery. With a focus on innovative solutions, she has developed a unique approach to enhance the efficacy of therapeutic compounds.
Latest Patents
Jayne Chin holds a patent for her invention titled "Chitosan covalently linked with small molecule integrin antagonist for targeted delivery." This invention relates to chitosan polymer derivatives that bind to integrin dimers, specifically alpha-4-beta-1 and alpha-V-beta-3. These derivatives can be utilized in delivery formulations to transport drugs, nucleic acids, or other therapeutic compounds to specific tissues or cells expressing these integrins. She has 1 patent to her name.
Career Highlights
Throughout her career, Jayne has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has contributed significantly to her expertise in drug delivery systems.
Collaborations
Jayne has collaborated with esteemed colleagues such as Robert Alan Goodnow, Jr. and Matthew Michael Hamilton. These partnerships have further enriched her work and innovation in the field.
Conclusion
Jayne Chin's innovative work in targeted drug delivery exemplifies her commitment to advancing medical science. Her contributions continue to pave the way for more effective therapeutic solutions.